These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 16900439)

  • 1. Risperidone augmentation of clozapine: a critical review.
    Kontaxakis VP; Ferentinos PP; Havaki-Kontaxaki BJ; Paplos KG; Pappa DA; Christodoulou GN
    Eur Arch Psychiatry Clin Neurosci; 2006 Sep; 256(6):350-5. PubMed ID: 16900439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized controlled augmentation trials in clozapine-resistant schizophrenic patients: a critical review.
    Kontaxakis VP; Ferentinos PP; Havaki-Kontaxaki BJ; Roukas DK
    Eur Psychiatry; 2005 Aug; 20(5-6):409-15. PubMed ID: 16171655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine resistance: augmentation strategies.
    Porcelli S; Balzarro B; Serretti A
    Eur Neuropsychopharmacol; 2012 Mar; 22(3):165-82. PubMed ID: 21906915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety.
    Anil Yağcioğlu AE; Kivircik Akdede BB; Turgut TI; Tümüklü M; Yazici MK; Alptekin K; Ertuğrul A; Jayathilake K; Göğüş A; Tunca Z; Meltzer HY
    J Clin Psychiatry; 2005 Jan; 66(1):63-72. PubMed ID: 15669890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
    Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of "atypical" antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder.
    Lerner V; Libov I; Kotler M; Strous RD
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):89-98. PubMed ID: 14687862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine affects the pharmacokinetics of risperidone and inhibits its metabolism and P-glycoprotein-mediated transport in vivo and in vitro: A safety attention to antipsychotic polypharmacy with clozapine and risperidone.
    Liu X; Sun H; Zhang Y; Sun Y; Wang W; Xu L; Liu W
    Toxicol Appl Pharmacol; 2021 Jul; 422():115560. PubMed ID: 33957192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case studies of adjunctive agents in clozapine-resistant schizophrenic patients.
    Kontaxakis VP; Ferentinos PP; Havaki-Kontaxaki BJ; Paplos KG; Roukas DK; Christodoulou GN
    Clin Neuropharmacol; 2005; 28(1):50-3. PubMed ID: 15711437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent administration of clozapine and electroconvulsive therapy in clozapine-resistant schizophrenia.
    Havaki-Kontaxaki BJ; Ferentinos PP; Kontaxakis VP; Paplos KG; Soldatos CR
    Clin Neuropharmacol; 2006; 29(1):52-6. PubMed ID: 16518135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risperidone as an adjunct to clozapine therapy in chronic schizophrenics.
    Henderson DC; Goff DC
    J Clin Psychiatry; 1996 Sep; 57(9):395-7. PubMed ID: 9746446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risperidone added to clozapine: impact on serum prolactin levels.
    Henderson DC; Goff DC; Connolly CE; Borba CP; Hayden D
    J Clin Psychiatry; 2001 Aug; 62(8):605-8. PubMed ID: 11561931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.
    Bondolfi G; Dufour H; Patris M; May JP; Billeter U; Eap CB; Baumann P
    Am J Psychiatry; 1998 Apr; 155(4):499-504. PubMed ID: 9545995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.
    Zink M; Kuwilsky A; Krumm B; Dressing H
    J Psychopharmacol; 2009 May; 23(3):305-14. PubMed ID: 18562423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
    Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M
    Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine and risperidone in moderately refractory schizophrenia: a 6-month randomized double-blind comparison.
    Schooler NR; Marder SR; Chengappa KN; Petrides G; Ames D; Wirshing WC; McMeniman M; Baker RW; Parepally H; Umbricht D; Kane JM
    J Clin Psychiatry; 2016 May; 77(5):628-34. PubMed ID: 27035871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mid-term and long-term efficacy and effectiveness of antipsychotic medications for schizophrenia: a data-driven, personalized clinical approach.
    Glick ID; Correll CU; Altamura AC; Marder SR; Csernansky JG; Weiden PJ; Leucht S; Davis JM
    J Clin Psychiatry; 2011 Dec; 72(12):1616-27. PubMed ID: 22244023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxic interaction between risperidone and clozapine: a case report.
    Kontaxakis VP; Havaki-Kontaxaki BJ; Stamouli SS; Christodoulou GN
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):407-9. PubMed ID: 11817521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.
    Citrome L; Volavka J; Czobor P; Sheitman B; Lindenmayer JP; McEvoy J; Cooper TB; Chakos M; Lieberman JA
    Psychiatr Serv; 2001 Nov; 52(11):1510-4. PubMed ID: 11684748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia.
    Li H; Rui Q; Ning X; Xu H; Gu N
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1002-8. PubMed ID: 21315787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.